Suthar Mehul S, Pulendran Bali
Department of Pediatrics and Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30329, USA; Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, GA 30329, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA; Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, GA 30329, USA.
Curr Opin Virol. 2014 Jun;6:70-5. doi: 10.1016/j.coviro.2014.04.010. Epub 2014 May 20.
Emerging and re-emerging mosquito-borne viruses continue to pose a significant threat to human health throughout the world. Over the past decade, West Nile virus (WNV), Dengue virus (DENV), and Chikungunya virus (CHIKV), have caused annual epidemics of virus-induced encephalitis, hemorrhagic fever\shock syndromes, and arthritis, respectively. Currently, no specific antiviral therapies or vaccines exist for use in humans to combat or prevent these viral infections. Thus, there is a pressing need to define the virus-host interactions that govern immunity and infection outcome. Recent technological breakthroughs in 'omics' resources and high-throughput based assays are beginning to accelerate antiviral drug discovery and improve on current strategies for vaccine design. In this review, we highlight studies with WNV and discuss how traditional and systems biological approaches are being used to rapidly identify novel host targets for therapeutic intervention and develop a deeper conceptual understanding of the host response to virus infection.
新出现和再次出现的蚊媒病毒继续对全球人类健康构成重大威胁。在过去十年中,西尼罗河病毒(WNV)、登革热病毒(DENV)和基孔肯雅病毒(CHIKV)分别引发了由病毒引起的脑炎、出血热/休克综合征和关节炎的年度流行。目前,尚无用于人类对抗或预防这些病毒感染的特异性抗病毒疗法或疫苗。因此,迫切需要确定控制免疫和感染结果的病毒-宿主相互作用。“组学”资源和基于高通量分析的最新技术突破正开始加速抗病毒药物的研发,并改进当前的疫苗设计策略。在这篇综述中,我们重点介绍了有关西尼罗河病毒的研究,并讨论了如何利用传统生物学方法和系统生物学方法快速识别用于治疗干预的新型宿主靶点,并对宿主对病毒感染的反应形成更深入的概念理解。